{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T03:38:17Z","timestamp":1780803497525,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,3,24]]},"DOI":"10.7759\/cureus.23469","type":"journal-article","created":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T02:14:08Z","timestamp":1648174448000},"source":"Crossref","is-referenced-by-count":1,"title":["Opsoclonus-Myoclonus in a Patient With Japanese Encephalitis: A Video-Based Case"],"prefix":"10.7759","author":[{"given":"Kumar","family":"Saurabh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyaz","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Japanese encephalitis. (n.d.). Accessed. January 26, 2022: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/japanese-encephalitis."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/s0022-510x(01)00589-5","article-title":"Seizures in Japanese encephalitis","volume":"190","author":"Misra UK","year":"2001","unstructured":"Misra UK, Kalita J. Seizures in Japanese encephalitis. J Neurol Sci. 2001, 190:57-60. 10.1016\/s0022-510x(01)00589-5","journal-title":"J Neurol Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.2007.77.528","article-title":"Long-term disability from acute childhood Japanese encephalitis in Shanghai, China","volume":"77","author":"Ding D","year":"2007","unstructured":"Ding D, Hong Z, Zhao SJ, et al.. Long-term disability from acute childhood Japanese encephalitis in Shanghai, China. Am J Trop Med Hyg. 2007, 77:528-33. 10.4269\/ajtmh.2007.77.528","journal-title":"Am J Trop Med Hyg"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s13256-017-1454-5","article-title":"Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report","volume":"11","author":"Sountharalingam S","year":"2017","unstructured":"Sountharalingam S, Herath HMMTB, Wijegunasinghe D, Senanayke S. Opsoclonus myoclonus syndrome in a patient with Japanese encephalitis: a case report. J Med Case Rep. 2017, 11:294. 10.1186\/s13256-017-1454-5","journal-title":"J Med Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1212\/wnl.53.8.1781","article-title":"Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis","volume":"53","author":"Pradhan S","year":"1999","unstructured":"Pradhan S, Pandey N, Shashank S, Gupta RK, Mathur A. Parkinsonism due to predominant involvement of substantia nigra in Japanese encephalitis. Neurology. 1999, 53:1781-6. 10.1212\/wnl.53.8.1781","journal-title":"Neurology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6118-6","article-title":"Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics","volume":"259","author":"Sarkari NB","year":"2012","unstructured":"Sarkari NB, Thacker AK, Barthwal SP, Mishra VK, Prapann S, Srivastava D, Sarkari M. Japanese encephalitis (JE). Part I: clinical profile of 1,282 adult acute cases of four epidemics. J Neurol. 2012, 259:47-57. 10.1007\/s00415-011-6118-6","journal-title":"J Neurol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/WCO.0b013e3280126b51","article-title":"An update on opsoclonus","volume":"20","author":"Wong A","year":"2007","unstructured":"Wong A. An update on opsoclonus. Curr Opin Neurol. 2007, 20:25-31. 10.1097\/WCO.0b013e3280126b51","journal-title":"Curr Opin Neurol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/124.2.437","article-title":"Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus","volume":"124","author":"Bataller L","year":"2001","unstructured":"Bataller L, Graus F, Saiz A, Vilchez JJ. Clinical outcome in adult onset idiopathic or paraneoplastic opsoclonus-myoclonus. Brain. 2001, 124:437-43. 10.1093\/brain\/124.2.437","journal-title":"Brain"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1007\/s002340050388","article-title":"MRI in Japanese encephalitis","volume":"39","author":"Kumar S","year":"1997","unstructured":"Kumar S, Misra UK, Kalita J, Salwani V, Gupta RK, Gujral R. MRI in Japanese encephalitis. Neuroradiology. 1997, 39:180-4. 10.1007\/s002340050388","journal-title":"Neuroradiology"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.4103\/2347-8659.135574","article-title":"Imaging and cytological analysis of 92 patients with Japanese encephalitis","volume":"1","author":"Meng Q","year":"2014","unstructured":"Meng Q, Zou YL, Bu H, He JY. Imaging and cytological analysis of 92 patients with Japanese encephalitis. Neuroimmunol Neuroinflamm. 2014, 1:29-34. 10.4103\/2347-8659.135574","journal-title":"Neuroimmunol Neuroinflamm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/1531-8257(200011)15:6<1168::aid-mds1016>3.0.co;2-v","article-title":"Markedly severe dystonia in Japanese encephalitis","volume":"15","author":"Kalita J","year":"2000","unstructured":"Kalita J, Misra UK. Markedly severe dystonia in Japanese encephalitis. Mov Disord. 2000, 15:1168-72. 10.1002\/1531-8257(200011)15:6&lt;1168::aid-mds1016&gt;3.0.co;2-v","journal-title":"Mov Disord"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0404.1997.tb00250.x","article-title":"Anterior horn cells are also involved in Japanese encephalitis","volume":"96","author":"Misra UK","year":"1997","unstructured":"Misra UK, Kalita J. Anterior horn cells are also involved in Japanese encephalitis. Acta Neurol Scand. 1997, 96:114-7. 10.1111\/j.1600-0404.1997.tb00250.x","journal-title":"Acta Neurol Scand"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2008.06.001","article-title":"Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome","volume":"44","author":"Pranzatelli MR","year":"2008","unstructured":"Pranzatelli MR, Tate ED, Hoefgen ER, Swan JA, Colliver JA. Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome. Cytokine. 2008, 44:26-32. 10.1016\/j.cyto.2008.06.001","journal-title":"Cytokine"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2013.01.011","article-title":"Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders","volume":"326","author":"Pranzatelli MR","year":"2013","unstructured":"Pranzatelli MR, Tate ED, McGee NR, Colliver JA. Cytokines, cytokine antagonists, and soluble adhesion molecules in pediatric OMS and other neuroinflammatory disorders. J Neurol Sci. 2013, 326:53-8. 10.1016\/j.jns.2013.01.011","journal-title":"J Neurol Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00468","article-title":"Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study","volume":"8","author":"Pranzatelli MR","year":"2017","unstructured":"Pranzatelli MR, Tate ED, McGee NR. Demographic, clinical, and immunologic features of 389 children with opsoclonus-myoclonus syndrome: a cross-sectional study. Front Neurol. 2017, 8:468. 10.3389\/fneur.2017.00468","journal-title":"Front Neurol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpn.2008.04.012","article-title":"Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma","volume":"13","author":"Raffaghello L","year":"2009","unstructured":"Raffaghello L, Conte M, De Grandis E, Pistoia V. Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. Eur J Paediatr Neurol. 2009, 13:219-23. 10.1016\/j.ejpn.2008.04.012","journal-title":"Eur J Paediatr Neurol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-4642(17)30130-X","article-title":"Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial","volume":"2","author":"de Alarcon PA","year":"2018","unstructured":"de Alarcon PA, Matthay KK, London WB, et al.. Intravenous immunoglobulin with prednisone and risk-adapted chemotherapy for children with opsoclonus myoclonus ataxia syndrome associated with neuroblastoma (ANBL00P3): a randomised, open-label, phase 3 trial. Lancet Child Adolesc Health. 2018, 2:25-34. 10.1016\/S2352-4642(17)30130-X","journal-title":"Lancet Child Adolesc Health"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000212991.64435.f0","article-title":"Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome","volume":"28","author":"Pranzatelli MR","year":"2006","unstructured":"Pranzatelli MR, Tate ED, Travelstead AL, et al.. Rituximab (anti-CD20) adjunctive therapy for opsoclonus-myoclonus syndrome. J Pediatr Hematol Oncol. 2006, 28:585-93. 10.1097\/01.mph.0000212991.64435.f0","journal-title":"J Pediatr Hematol Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1016\/j.braindev.2015.11.007","article-title":"Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome","volume":"38","author":"Pranzatelli MR","year":"2016","unstructured":"Pranzatelli MR, Tate ED. Trends and tenets in relapsing and progressive opsoclonus-myoclonus syndrome. Brain Dev. 2016, 38:439-48. 10.1016\/j.braindev.2015.11.007","journal-title":"Brain Dev"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.241404","article-title":"Pediatric opsoclonus-myoclonus-ataxia syndrome: experience from a tertiary care university hospital","volume":"66","author":"Huddar A","year":"2018","unstructured":"Huddar A, Bindu PS, Nagappa M, Bharath RD, Sinha S, Mathuranath PS, Taly AB. Pediatric opsoclonus-myoclonus-ataxia syndrome: experience from a tertiary care university hospital. Neurol India. 2018, 66:1332-7. 10.4103\/0028-3886.241404","journal-title":"Neurol India"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/91380-opsoclonus-myoclonus-in-a-patient-with-japanese-encephalitis-a-video-based-case","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:43:17Z","timestamp":1707507797000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/91380-opsoclonus-myoclonus-in-a-patient-with-japanese-encephalitis-a-video-based-case"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3,24]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.23469","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3,24]]}}}